Literature DB >> 33692478

Protein network analyses of pulmonary endothelial cells in chronic thromboembolic pulmonary hypertension.

Sarath Babu Nukala1,2, Olga Tura-Ceide3,4,5, Marta Cascante6,7, Alfonsina D'Amato8, Giancarlo Aldini9, Valérie F E D Smolders6,3, Isabel Blanco3,4, Victor I Peinado3,4, Manuel Castellà10, Joan Albert Barberà3,4, Alessandra Altomare9, Giovanna Baron9, Marina Carini9.   

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is a vascular disease characterized by the presence of organized thromboembolic material in pulmonary arteries leading to increased vascular resistance, heart failure and death. Dysfunction of endothelial cells is involved in CTEPH. The present study describes for the first time the molecular processes underlying endothelial dysfunction in the development of the CTEPH. The advanced analytical approach and the protein network analyses of patient derived CTEPH endothelial cells allowed the quantitation of 3258 proteins. The 673 differentially regulated proteins were associated with functional and disease protein network modules. The protein network analyses resulted in the characterization of dysregulated pathways associated with endothelial dysfunction, such as mitochondrial dysfunction, oxidative phosphorylation, sirtuin signaling, inflammatory response, oxidative stress and fatty acid metabolism related pathways. In addition, the quantification of advanced oxidation protein products, total protein carbonyl content, and intracellular reactive oxygen species resulted increased attesting the dysregulation of oxidative stress response. In conclusion this is the first quantitative study to highlight the involvement of endothelial dysfunction in CTEPH using patient samples and by network medicine approach.

Entities:  

Mesh:

Year:  2021        PMID: 33692478      PMCID: PMC7946953          DOI: 10.1038/s41598-021-85004-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  48 in total

1.  Effects of C-reactive protein on human pulmonary vascular cells in chronic thromboembolic pulmonary hypertension.

Authors:  Marijke Wynants; Rozenn Quarck; Alicja Ronisz; Ernesto Alfaro-Moreno; Dirk Van Raemdonck; Bart Meyns; Marion Delcroix
Journal:  Eur Respir J       Date:  2012-01-20       Impact factor: 16.671

2.  Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature.

Authors:  Peter Dorfmüller; Sven Günther; Maria-Rosa Ghigna; Vincent Thomas de Montpréville; David Boulate; Jean-François Paul; Xavier Jaïs; Benoit Decante; Gérald Simonneau; Philippe Dartevelle; Marc Humbert; Elie Fadel; Olaf Mercier
Journal:  Eur Respir J       Date:  2014-08-19       Impact factor: 16.671

Review 3.  Chronic thromboembolic pulmonary hypertension.

Authors:  Nick H Kim; Marion Delcroix; David P Jenkins; Richard Channick; Philippe Dartevelle; Pavel Jansa; Irene Lang; Michael M Madani; Hitoshi Ogino; Vittorio Pengo; Eckhard Mayer
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

Review 4.  Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases.

Authors:  Maria Angela Incalza; Rossella D'Oria; Annalisa Natalicchio; Sebastio Perrini; Luigi Laviola; Francesco Giorgino
Journal:  Vascul Pharmacol       Date:  2017-06-01       Impact factor: 5.773

Review 5.  Endothelial and smooth muscle cell ion channels in pulmonary vasoconstriction and vascular remodeling.

Authors:  Ayako Makino; Amy L Firth; Jason X-J Yuan
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

Review 6.  NADPH oxidases in vascular pathology.

Authors:  Anna Konior; Agata Schramm; Marta Czesnikiewicz-Guzik; Tomasz J Guzik
Journal:  Antioxid Redox Signal       Date:  2013-11-01       Impact factor: 8.401

Review 7.  Hematological disorders and pulmonary hypertension.

Authors:  Rajamma Mathew; Jing Huang; Joseph M Wu; John T Fallon; Michael H Gewitz
Journal:  World J Cardiol       Date:  2016-12-26

8.  Chronic thromboembolic pulmonary hypertension.

Authors:  Nick H Kim; Marion Delcroix; Xavier Jais; Michael M Madani; Hiromi Matsubara; Eckhard Mayer; Takeshi Ogo; Victor F Tapson; Hossein-Ardeschir Ghofrani; David P Jenkins
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

9.  The pro-fibrotic properties of transforming growth factor on human fibroblasts are counteracted by caffeic acid by inhibiting myofibroblast formation and collagen synthesis.

Authors:  Masum M Mia; Ruud A Bank
Journal:  Cell Tissue Res       Date:  2015-10-09       Impact factor: 5.249

Review 10.  Reactive Oxygen Species: A Key Constituent in Cancer Survival.

Authors:  Seema Kumari; Anil Kumar Badana; Murali Mohan G; Shailender G; RamaRao Malla
Journal:  Biomark Insights       Date:  2018-02-06
View more
  1 in total

1.  The alterations in molecular markers and signaling pathways in chronic thromboembolic pulmonary hypertension, a study with transcriptome sequencing and bioinformatic analysis.

Authors:  Wenqing Xu; Mei Deng; Xiapei Meng; Xuebiao Sun; Xincao Tao; Dingyi Wang; Shuai Zhang; Yanan Zhen; Xiaopeng Liu; Min Liu
Journal:  Front Cardiovasc Med       Date:  2022-07-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.